Hercules Capital (NYSE:HTGC) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Key Points

• Hercules reported Q1 EPS of $0.48, beating estimates by $0.01, but revenue of $134.94M missed consensus; the firm set records with $1.81B of new commitments, strong investment income and about $6.1B in AUM, and raised roughly $300M of notes plus ~$52M via an ATM to fund growth.
• Leverage increased materially to a GAAP level of 115.4% (from 104.4%), driving higher interest expense (~$30.8M) and putting the company at the high end of its historical leverage range.
• Hercules faces elevated legal and reputational risk after the Hunterbrook report spurred multiple securities class-action filings, and several analysts have trimmed price targets even as the consensus rating remains a "Moderate Buy."

Hercules Capital (NYSE:HTGC - Get Free Report) announced its quarterly earnings results on Tuesday. The financial services provider reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.01, Zacks reports. Hercules Capital had a return on equity of 15.97% and a net margin of 63.80%.The firm had revenue of $134.94 million for the quarter, compared to the consensus estimate of $141.39 million. During the same period in the prior year, the company posted $0.45 earnings per share. The company's quarterly revenue was up 18.4% on a year-over-year basis.

Here are the key takeaways from Hercules Capital's conference call:

• Hercules reported all-time records for originations and income — $1.81 billion of new commitments in Q1, $141.5 million total investment income and $88.1 million net investment income, with assets under management of about $6.1 billion.
• Liquidity and capital access are strong — the BDC held $454.5 million of available liquidity and the platform had over $1 billion, while management raised $300 million of 2029 notes and ~$52 million via the ATM to fund growth and opportunistic deployments.
• Leverage increased materially to a GAAP level of 115.4% (up from 104.4%), driving higher interest expense (~$30.8 million) and putting the company at the high end of its historical leverage range.
• Credit metrics remain healthy — weighted average internal rating was 2.11, Grade 1–2 credits rose to 70.5%, only one loan on non-accrual (~0.2% of cost), and PIK declined to ~9.1% with most PIK being contractual (not distress) and being collected in cash.

Hercules Capital Stock Performance

NYSE HTGC traded up $0.13 during trading hours on Tuesday, hitting $16.57. 2,062,794 shares of the company's stock traded hands, compared to its average volume of 2,449,082. Hercules Capital has a 52 week low of $13.70 and a 52 week high of $19.67. The firm has a market capitalization of $3.10 billion, a P/E ratio of 9.05 and a beta of 0.82. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 1.03. The business's fifty day moving average price is $14.92 and its two-hundred day moving average price is $16.91.

Hercules Capital Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 21st. Investors of record on Thursday, May 14th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Thursday, May 14th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.7%. Hercules Capital's dividend payout ratio (DPR) is presently 87.43%.

Insider Buying and Selling at Hercules Capital

In related news, CFO Seth H. Meyer purchased 7,000 shares of Hercules Capital stock in a transaction on Friday, February 27th. The stock was acquired at an average price of $14.33 per share, for a total transaction of $100,310.00. Following the completion of the transaction, the chief financial officer directly owned 448,553 shares in the company, valued at $6,427,764.49. This represents a 1.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gayle A. Crowell acquired 6,600 shares of the firm's stock in a transaction dated Monday, February 23rd. The stock was bought at an average cost of $15.20 per share, for a total transaction of $100,320.00. Following the purchase, the director directly owned 87,458 shares of the company's stock, valued at approximately $1,329,361.60. This trade represents a 8.16% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 117,015 shares of company stock worth $1,749,620. Insiders own 1.80% of the company's stock.

Hedge Funds Weigh In On Hercules Capital

Several large investors have recently added to or reduced their stakes in HTGC. Marshall Wace LLP purchased a new stake in shares of Hercules Capital in the third quarter worth $11,199,000. Qube Research & Technologies Ltd lifted its stake in shares of Hercules Capital by 425.6% during the 2nd quarter. Qube Research & Technologies Ltd now owns 580,414 shares of the financial services provider's stock valued at $10,610,000 after buying an additional 469,989 shares in the last quarter. HRT Financial LP boosted its holdings in Hercules Capital by 100.9% in the 2nd quarter. HRT Financial LP now owns 558,010 shares of the financial services provider's stock worth $10,200,000 after buying an additional 280,198 shares during the period. Credit Agricole S A purchased a new stake in Hercules Capital in the 3rd quarter worth $5,271,000. Finally, Jump Financial LLC increased its stake in Hercules Capital by 150.6% in the 4th quarter. Jump Financial LLC now owns 361,092 shares of the financial services provider's stock worth $6,796,000 after buying an additional 217,017 shares in the last quarter. Hedge funds and other institutional investors own 19.69% of the company's stock.

Key Headlines Impacting Hercules Capital

Here are the key news stories impacting Hercules Capital this week:

• Positive Sentiment: Hercules provided new financing to Lexicon Pharmaceuticals — a loan facility up to $100 million that expands Hercules’ origination pipeline and future interest income potential. Lexicon loan
• Positive Sentiment: Hercules amended a loan agreement with Senseonics to increase the borrower’s capacity to $140 million — another sign of deal flow and supporting near-term revenue visibility. Senseonics amendment
• Neutral Sentiment: Citizens cut its price target on HTGC but kept an Outperform rating — a mixed signal that preserves analyst support while lowering upside expectations. Citizens note
• Negative Sentiment: Q1 results missed consensus: HTGC reported $0.23 EPS vs. $0.47 expected and revenue of $134.94M vs. $141.39M — a clear near-term earnings disappointment that can pressure multiple/valuation. Q1 press release
• Negative Sentiment: Multiple law firms have filed or are soliciting lead-plaintiff motions in securities class actions alleging misconduct linked to a critical Hunterbrook report; deadlines for lead plaintiff motions are being publicized (May 19–21). This widespread litigation activity increases legal risk, potential settlements, and reputational pressure. Pomerantz alert
• Negative Sentiment: Hagens Berman and others cite allegations from the Hunterbrook report alleging copied sourcing, misstated marks and PIK loan concerns — these substantive allegations are likely fueling investor and litigation attention. Hagens Berman alert

Analyst Ratings Changes

A number of analysts have recently issued reports on HTGC shares. Citizens Jmp dropped their price target on shares of Hercules Capital from $24.00 to $22.00 and set a "market outperform" rating on the stock in a report on Wednesday, April 22nd. Keefe, Bruyette & Woods lowered their price objective on shares of Hercules Capital from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Thursday, April 16th. Wells Fargo & Company cut their target price on shares of Hercules Capital from $18.00 to $17.00 and set an "overweight" rating for the company in a research report on Friday, February 13th. Piper Sandler decreased their target price on shares of Hercules Capital from $17.50 to $16.50 and set a "neutral" rating for the company in a research note on Tuesday, April 7th. Finally, Weiss Ratings downgraded Hercules Capital from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $18.04.

Hercules Capital Company Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company's investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.